Atezolizumab,Bevacizumab
Roche
['tecentriq', '$rhhby', 'roche,(-broche),(-rocheter)']
roche's tecentriq lowers liver cancer relapse by 28% after surgical resection #aacr23 $rhhby 
The latest global #pharma news, insights, analysis, and views providing you with an information edge.  FirstWord Pharma. Where people who know first, go first.